findmyKOL

Silvi Shah, MD

Basic profile

Nephrology

ORCID↗NPI↗
✓ Full record
RegionCincinnati, OH · MidwestSpecialtyNephrologyFocusNephrology
Active KOLfindmyKOL type: RegionalLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH funding2021–2025

Silvi Shah is a Nephrology physician. OpenAlex indexes 116 publications with 1,442 citations (h-index 20).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
116publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,442citations

Total citations across indexed works.

20h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
16companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 2021–2025

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

234 Goodman St
Cincinnati, OH 452192364

Telephone

513-584-4956

Registry record last updated 17 Aug 2017.

View the NPPES registry record

Industry payments

16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    54.4%
    Calcium channel blocker29.2%
    Nifedipine Er100%
    Part D≥18 patients
    Beta blocker20.4%
    Carvedilol79%Metoprolol Tartrate21%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    20.4%
    Corticosteroid8.4%
    Prednisone100%
    Part D<11 patients
    Vitamin D3 Analog6.9%
    Calcitriol100%
    Part D<11 patients

    + 1 more class in this area

  • Hormonal (systemic)

    12%
    Calcium-sensing Receptor Agonist12%
    Cinacalcet Hcl100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 2021–2025 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”